The same mealtime insulin, insulin aspart (NovoRapid outside the US) — vials and pens priced from official databases in six places.
Researched with AI assistance; every figure is checked against the primary source cited on this page before publishing. How we work →
One 10 mL vial (1,000 units) of insulin aspart 100 units/mL, and a box of five 3 mL pens (1,500 units) where official lists give one. Each country's own official price; US prices are per mL and multiplied by 10 or 15 (our calculation). US dollars at European Central Bank reference rates of October 30, 2026. How much insulin a person needs varies, so we compare packs, not months.
NOVOLOG / NOVORAPID (INSULIN ASPART) · ONE 10 ML VIAL
Price by country, November 2026
US figures per mL × 10 (our calculation). Medicare patients pay at most $35 a month per insulin product.
| Country | Official price | 30 days in US dollars | What a patient typically pays |
|---|---|---|---|
| 🇺🇸 United States (pharmacy cost) | NovoLog vial $6.93278 per mL; FlexPen $8.93367 per mL; unbranded insulin aspart vial $6.95482; biosimilar Merilog vial $6.8159 (CMS NADAC, Oct 28, 2026) | vial $69 · 5 pens $134 | Medicare: at most $35 a month per insulin product |
| 🇺🇸 United States (Medicare) | Vial $6.956927 per mL, FlexPen $8.956984 per mL in 2026, ending Dec 31, 2026 (CMS price file); $119 per 30-day supply, 2023 list price $495 (CMS fact sheet) | vial $70 · 5 pens $134 | At most $35 a month, no deductible |
| 🇬🇧 United Kingdom | NovoRapid vial £14.08 (since Apr 15, 2013); 5 FlexPens £30.60 (since 2011); Trurapi 5 pens £21.42 (NHS prices) | vial $19 · 5 pens $41 | England: £9.90 per item; free for people with diabetes on insulin who hold an exemption certificate |
| 🇫🇷 France | Vial €12.83; 5 FlexPens €22.20 (official prices excluding dispensing fee) | vial $14 · 5 pens $25 | 35% of the price unless a complementary insurer covers it (65% reimbursed) |
| 🇨🇭 Switzerland | Vial CHF 37.90; 5 FlexPens CHF 56.60 (public prices) | vial $46 · 5 pens $69 | 10% share after the annual deductible |
| 🇦🇹 Austria | Vial €28.10; 5 Penfill cartridges €41.75 (social-insurance prices excl. VAT; FlexPen not listed) | vial $31 · 5 cartridges $47 | €7.55 prescription fee per pack |
| 🇳🇱 Netherlands | Vial €16.47 (average pharmacy price) | vial $18 | Reimbursed under conditions; counts toward the annual deductible |
| 🇩🇪 Germany | No statutory price ceiling (Festbetrag) for insulin aspart | — | Co-payment of at most €10 per pack (€15 from 2027) |
We compare prices; we do not recommend where to buy medicine. Insulin type and dose are decisions for your doctor or diabetes team — never ration insulin to save money.
NovoLog's pharmacy acquisition cost is $6.93 per mL for the vial (NADAC, October 28, 2026), and Medicare's negotiated price for 2026 is $6.96 per mL (CMS price file). Medicare patients pay at most $35 a month per covered insulin product. CMS's price file ends the negotiated price for NovoLog and Fiasp on December 31, 2026 and marks them as deselected; Novo's unbranded insulin aspart and the biosimilar Merilog are already listed in the pharmacy-price survey at about the same price.
A 10 mL vial costs €12.83 in France, €16.47 in the Netherlands, £14.08 in the UK (a price unchanged since 2013) and CHF 37.90 in Switzerland — about $14 to $46. Five pre-filled pens cost €22.20 in France, £30.60 in the UK and CHF 56.60 in Switzerland, against about $134 at US pharmacy cost.
The German statutory price-ceiling (Festbetrag) list of October 15, 2026 has no group for insulin aspart, and we found no freely published official pharmacy price, so we show none. Insured patients pay a co-payment of 10%, at least €5 and at most €10 per pack (€7.50 to €15 from 2027). Our insulin overview compares other insulins: see insulin prices by country.
US pharmacies pay about $69 for a 10 mL vial of NovoLog and about $134 for five FlexPens (CMS NADAC, October 28, 2026). Official prices for NovoRapid elsewhere: €12.83 for a vial in France, €16.47 in the Netherlands, £14.08 in the UK and CHF 37.90 in Switzerland — roughly $14 to $46 at ECB rates.
At most $35 for a one-month supply of each covered insulin product, and no deductible applies (Medicare.gov). Medicare's negotiated price for NovoLog applies in 2026 only, according to CMS's price file.
Yes: insulin aspart from Novo Nordisk is sold as NovoLog in the US and as NovoRapid in Europe. The UK also lists Trurapi, another insulin aspart, at £21.42 for five pens; the US lists Merilog and Novo's unbranded insulin aspart.
CMS's maximum-fair-price file of November 2, 2026 ends the negotiated price for NovoLog and Fiasp on December 31, 2026 and marks them as deselected. Medicare patients' $35 monthly cap for covered insulin continues under separate rules.
There is no statutory price ceiling for insulin aspart (list of October 15, 2026), and we found no freely published official pharmacy price. Insured patients pay at most €10 per pack (€15 from 2027).
Wellness Vision does not sell medicine, recommend pharmacies or suppliers, or take payments from drug makers. Every price above comes from the official source cited; conversions and per-30-tablet figures are our own calculations, shown with their formula. This is a cost comparison, not medical advice.
You shouldn't have to go broke to feel whole.
